Benzyl butyl phthalate increases the chemoresistance to doxorubicin/cyclophosphamide by increasing breast cancer-associated dendritic cell-derived CXCL1/GROα and S100A8/A9

  • Authors:
    • Ya-Ling Hsu
    • Jen-Yu Hung
    • Eing-Mei Tsai
    • Cheng-Ying Wu
    • Ya-Wen Ho
    • Shu-Fang Jian
    • Meng-Chi Yen
    • Wei-An Chang
    • Ming-Feng Hou
    • Po-Lin Kuo
  • View Affiliations

  • Published online on: September 23, 2015     https://doi.org/10.3892/or.2015.4307
  • Pages: 2889-2900
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Phthalates are used as plasticizers in the manufacture of flexible vinyl, which is used in food contact applications. Phthalates have been demonstrated to have an adverse impact on human health, particularly in terms of cancer development. In the present study, we showed for the first time that benzyl butyl phthalate (BBP) potentiates the effect of tumor‑associated dendritic cells (TADCs) on the chemoresistance of breast cancer. Specific knockdown analysis revealed that S100A9 is the major factor responsible for the chemoresistance of doxorubicin/cyclophosphamide induced by BBP-stimulated TADCs in breast cancer. BBP exposure also increased tumor infiltrating myeloid-derived suppressor cell (MDSC) secretion of S100A8/A9, thereby exacerbating the resistance of breast cancer to doxorubicin with cyclophosphamide. In addition, BBP also stimulated the production of CXCL1/GROα by TADCs, which increased the angiogenesis of breast cancer in a mouse model. Inhibition of CXCL1/GROα by a neutralizing antibody, decreased the BBP-induced angiogenesis induced by BBP after chemotherapy in the mouse model. These results, for the first time, provide evidence that BBP influences the efficacy of chemotherapy by remodeling the tumor microenvironment of breast cancer.
View Figures
View References

Related Articles

Journal Cover

December-2015
Volume 34 Issue 6

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Hsu Y, Hung J, Tsai E, Wu C, Ho Y, Jian S, Yen M, Chang W, Hou M, Kuo P, Kuo P, et al: Benzyl butyl phthalate increases the chemoresistance to doxorubicin/cyclophosphamide by increasing breast cancer-associated dendritic cell-derived CXCL1/GROα and S100A8/A9. Oncol Rep 34: 2889-2900, 2015
APA
Hsu, Y., Hung, J., Tsai, E., Wu, C., Ho, Y., Jian, S. ... Kuo, P. (2015). Benzyl butyl phthalate increases the chemoresistance to doxorubicin/cyclophosphamide by increasing breast cancer-associated dendritic cell-derived CXCL1/GROα and S100A8/A9. Oncology Reports, 34, 2889-2900. https://doi.org/10.3892/or.2015.4307
MLA
Hsu, Y., Hung, J., Tsai, E., Wu, C., Ho, Y., Jian, S., Yen, M., Chang, W., Hou, M., Kuo, P."Benzyl butyl phthalate increases the chemoresistance to doxorubicin/cyclophosphamide by increasing breast cancer-associated dendritic cell-derived CXCL1/GROα and S100A8/A9". Oncology Reports 34.6 (2015): 2889-2900.
Chicago
Hsu, Y., Hung, J., Tsai, E., Wu, C., Ho, Y., Jian, S., Yen, M., Chang, W., Hou, M., Kuo, P."Benzyl butyl phthalate increases the chemoresistance to doxorubicin/cyclophosphamide by increasing breast cancer-associated dendritic cell-derived CXCL1/GROα and S100A8/A9". Oncology Reports 34, no. 6 (2015): 2889-2900. https://doi.org/10.3892/or.2015.4307